Fig. 3From: Duplex sequencing identifies genomic features that determine susceptibility to benzo(a)pyrene-induced in vivo mutationsDuplex Sequencing background (A) and BaP-induced (B-D) mutation frequency per target relative to guanine/cytosine content. Data are presented separately for intergenic (red) and genic (black) targets. Vehicle controls (A); 12.5 (B), 25 (C) and 50 (D) mg/kg BaP doseBack to article page